PL366744A1 - Pojedyncza dawka inhibitora aromatazy do leczenianiepłodności - Google Patents

Pojedyncza dawka inhibitora aromatazy do leczenianiepłodności

Info

Publication number: PL366744A1
Authority: PL; Poland
Prior art keywords: single dose; aromatase inhibitor; treating infertility; dose aromatase; infertility
Prior art date: 2001-04-17

Application number

PL02366744A

Other languages

English (en)

Inventor

Robert F. Casper

Mohamed F.M. Mitwally

Original Assignee

Ares Trading S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-17

Filing date

2002-04-17

Publication date

2005-02-07

2002-04-17 Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.

2005-02-07 Publication of PL366744A1 publication Critical patent/PL366744A1/pl

Links

229940122815 Aromatase inhibitor Drugs 0.000 title 1
239000003886 aromatase inhibitor Substances 0.000 title 1
208000000509 infertility Diseases 0.000 title 1
230000036512 infertility Effects 0.000 title 1
231100000535 infertility Toxicity 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL02366744A 2001-04-17 2002-04-17 Pojedyncza dawka inhibitora aromatazy do leczenianiepłodności PL366744A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28428201P	2001-04-17	2001-04-17

Publications (1)

Publication Number	Publication Date
PL366744A1 true PL366744A1 (pl)	2005-02-07

Family

ID=23089583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02366744A PL366744A1 (pl)	2001-04-17	2002-04-17	Pojedyncza dawka inhibitora aromatazy do leczenianiepłodności

Country Status (32)

Country	Link
US (1)	US8008333B2 (pl)
EP (1)	EP1383578B1 (pl)
JP (1)	JP2004529924A (pl)
KR (1)	KR20040025916A (pl)
CN (1)	CN1551789A (pl)
AR (1)	AR034036A1 (pl)
AT (1)	ATE409066T1 (pl)
AU (1)	AU2002249043B2 (pl)
BG (1)	BG108323A (pl)
BR (1)	BR0208920A (pl)
CA (1)	CA2444980C (pl)
CY (1)	CY1108648T1 (pl)
CZ (1)	CZ20033107A3 (pl)
DE (1)	DE60229047D1 (pl)
DK (1)	DK1383578T3 (pl)
EA (1)	EA011310B1 (pl)
EE (1)	EE200300505A (pl)
ES (1)	ES2311599T3 (pl)
HR (1)	HRP20030839A2 (pl)
HU (1)	HUP0304003A2 (pl)
IL (1)	IL158396A0 (pl)
MX (1)	MXPA03009447A (pl)
NO (1)	NO20034246L (pl)
NZ (1)	NZ552873A (pl)
PL (1)	PL366744A1 (pl)
PT (1)	PT1383578E (pl)
SI (1)	SI1383578T1 (pl)
SK (1)	SK14242003A3 (pl)
UA (1)	UA82648C2 (pl)
WO (1)	WO2002083241A1 (pl)
YU (1)	YU81203A (pl)
ZA (1)	ZA200307516B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL373219A1 (pl) *	2002-07-02	2005-08-22	Pharmacia & Upjohn Company Llc	Leczenie bezpłodności eksemestanem
US7153824B2 (en)	2003-04-01	2006-12-26	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
CA2619503A1 (en) *	2005-06-28	2007-01-04	Robert F. Casper	Aromatase inhibitors for emergency contraception
WO2007081980A2 (en) *	2006-01-10	2007-07-19	Diobex, Inc.	Methods and compositions for treating prostate cancer
WO2011143752A1 (en) *	2010-05-20	2011-11-24	University Of Saskatchewan	Use of aromatase inhibitors for synchronizing ovulation, inducing superovulation or double ovulation and improving twinning and fertility in a mammal
WO2014169395A1 (en)	2013-04-19	2014-10-23	University Of Saskatchewan	Aromatase inhibitor-releasing intravaginal device
US20160022644A1 (en) *	2014-07-22	2016-01-28	Tsu-I Catherine Wang	Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4728645A (en) *	1982-12-21	1988-03-01	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4845227A (en) *	1984-06-18	1989-07-04	Eli Lilly And Company	Aromatase inhibitors from azoles
US4602025A (en) *	1984-06-18	1986-07-22	Eli Lilly And Company	Aromatase inhibitors
US4978672A (en) *	1986-03-07	1990-12-18	Ciba-Geigy Corporation	Alpha-heterocyclc substituted tolunitriles
GB8726505D0 (en) *	1987-11-12	1987-12-16	Ici Plc	Naphtho(2 1-b)furan derivatives
DE4330237C2 (de)	1993-09-02	1995-11-30	Schering Ag	1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
CA2250908C (en) *	1996-04-30	2012-03-13	Takeda Chemical Industries, Ltd.	Combined use of gnrh agonist and antagonist
DE19622457A1 (de)	1996-05-24	1997-11-27	Schering Ag	7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US6953774B2 (en) *	2000-08-11	2005-10-11	Applied Research Systems Ars Holding N.V.	Methods of inducing ovulation

2002
- 2002-04-17 HR HR20030839A patent/HRP20030839A2/hr not_active Application Discontinuation
- 2002-04-17 DK DK02717919T patent/DK1383578T3/da active
- 2002-04-17 AR ARP020101399A patent/AR034036A1/es unknown
- 2002-04-17 DE DE60229047T patent/DE60229047D1/de not_active Expired - Lifetime
- 2002-04-17 HU HU0304003A patent/HUP0304003A2/hu unknown
- 2002-04-17 WO PCT/CA2002/000527 patent/WO2002083241A1/en not_active Ceased
- 2002-04-17 SK SK1424-2003A patent/SK14242003A3/sk unknown
- 2002-04-17 JP JP2002581041A patent/JP2004529924A/ja active Pending
- 2002-04-17 CN CNA028120825A patent/CN1551789A/zh active Pending
- 2002-04-17 NZ NZ552873A patent/NZ552873A/en not_active IP Right Cessation
- 2002-04-17 BR BR0208920-3A patent/BR0208920A/pt not_active IP Right Cessation
- 2002-04-17 MX MXPA03009447A patent/MXPA03009447A/es not_active Application Discontinuation
- 2002-04-17 UA UA20031110268A patent/UA82648C2/uk unknown
- 2002-04-17 AT AT02717919T patent/ATE409066T1/de active
- 2002-04-17 YU YU81203A patent/YU81203A/sh unknown
- 2002-04-17 EP EP02717919A patent/EP1383578B1/en not_active Expired - Lifetime
- 2002-04-17 EE EEP200300505A patent/EE200300505A/xx unknown
- 2002-04-17 CZ CZ20033107A patent/CZ20033107A3/cs unknown
- 2002-04-17 CA CA2444980A patent/CA2444980C/en not_active Expired - Fee Related
- 2002-04-17 AU AU2002249043A patent/AU2002249043B2/en not_active Ceased
- 2002-04-17 PL PL02366744A patent/PL366744A1/pl not_active Application Discontinuation
- 2002-04-17 SI SI200230747T patent/SI1383578T1/sl unknown
- 2002-04-17 IL IL15839602A patent/IL158396A0/xx unknown
- 2002-04-17 EA EA200301128A patent/EA011310B1/ru not_active IP Right Cessation
- 2002-04-17 PT PT02717919T patent/PT1383578E/pt unknown
- 2002-04-17 KR KR10-2003-7013484A patent/KR20040025916A/ko not_active Ceased
- 2002-04-17 US US10/475,101 patent/US8008333B2/en not_active Expired - Fee Related
- 2002-04-17 ES ES02717919T patent/ES2311599T3/es not_active Expired - Lifetime
2003
- 2003-09-23 NO NO20034246A patent/NO20034246L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307516A patent/ZA200307516B/en unknown
- 2003-11-07 BG BG108323A patent/BG108323A/bg unknown
2008
- 2008-12-12 CY CY20081101446T patent/CY1108648T1/el unknown

Also Published As

Publication number	Publication date
BR0208920A (pt)	2004-04-20
HUP0304003A2 (hu)	2004-04-28
NO20034246D0 (no)	2003-09-23
SI1383578T1 (sl)	2008-12-31
MXPA03009447A (es)	2004-05-24
DK1383578T3 (da)	2008-11-03
EP1383578A1 (en)	2004-01-28
AU2002249043B2 (en)	2008-01-10
ES2311599T3 (es)	2009-02-16
ZA200307516B (en)	2004-09-27
EP1383578B1 (en)	2008-09-24
CN1551789A (zh)	2004-12-01
NO20034246L (no)	2003-12-15
CA2444980A1 (en)	2002-10-24
NZ552873A (en)	2008-05-30
CA2444980C (en)	2010-08-17
ATE409066T1 (de)	2008-10-15
SK14242003A3 (sk)	2004-03-02
IL158396A0 (en)	2004-05-12
US20040171660A1 (en)	2004-09-02
PT1383578E (pt)	2008-10-08
BG108323A (bg)	2004-12-30
UA82648C2 (uk)	2008-05-12
AR034036A1 (es)	2004-01-21
EE200300505A (et)	2004-02-16
EA011310B1 (ru)	2009-02-27
EA200301128A1 (ru)	2004-04-29
CZ20033107A3 (en)	2004-03-17
HRP20030839A2 (en)	2005-08-31
US8008333B2 (en)	2011-08-30
CY1108648T1 (el)	2014-04-09
DE60229047D1 (de)	2008-11-06
WO2002083241A1 (en)	2002-10-24
YU81203A (sh)	2006-05-25
KR20040025916A (ko)	2004-03-26
JP2004529924A (ja)	2004-09-30

Legal Events

Date	Code	Title	Description
2009-11-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL233205B (en)	2020-04-30	Substances for the treatment or prevention of pre-eclampsia
IL159376A (en)	2010-12-30	Apparatus for acne treatment
GB0316313D0 (en)	2003-08-13	Methods for specifically inhibiting histone deacetylase-4
EP1465968A4 (en)	2005-12-14	METHODS OF TREATING DISTILLATE DEODORIZER
EP1414492A4 (en)	2005-12-21	METHOD FOR THE TREATMENT OF MULTIPLE MYELOMA
EP1581234A4 (en)	2007-09-12	METHODS FOR TREATING MIGRAINE
SI1383578T1 (sl)	2008-12-31	Enkratna doza zaviralca aromataze za zdravljenje neplodnosti
IL144900A0 (en)	2002-06-30	Method for treating primary insomnia
EP1535577A4 (en)	2008-03-12	LIGA TION TREATMENT UNIT
ZA200306122B (en)	2004-11-08	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
IL150837A0 (en)	2003-02-12	Use of fsh for treating infertility
PT1400522E (pt)	2014-10-30	Compostos para tratar a impotência
EP1444983A4 (en)	2006-11-08	AGENTS FOR THE TREATMENT OF INFLAMMATORY ABDOMINAL DISEASES
IL158395A0 (en)	2004-05-12	Aromatase inhibitor for use in reproduction
IL156729A0 (en)	2004-02-08	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
AU2001252065A1 (en)	2002-10-28	Multiple dose aromatase inhibitor for treating infertility
GB0125594D0 (en)	2001-12-19	Inhibitors for inactivating allergens
AU2002250752A1 (en)	2002-10-28	Aromatase inhibitors for treating infertility
HU0001889D0 (en)	2000-07-28	Pharmaceutical composition for treating migraine
AU2003251208A8 (en)	2004-03-19	Apparatus for treating strip-shaped parts
IL160703A0 (en)	2004-08-31	Method for treating coumarin-induced hemorrhage
EP1549327A4 (en)	2009-06-10	COMPOSITION FOR THE TREATMENT OF HEMORROIDS
GB0123063D0 (en)	2001-11-14	Compositions for therapy
CZ20011275A3 (cs)	2002-11-13	AFB1 - Cytostatikum na léčbu primárního hepatoblastomu
GB0102559D0 (en)	2001-03-21	Treatment for angiogenesis-dependant condition